Connecting with the Global Laboratory Medicine Frontier｜Hotgen Showcases Innovative Immunodiagnostic Solutions at ADLM 2026

From July 28-30, 2026, ADLM 2026 Annual Scientific Meeting & Clinical Lab Expo, a premier global event in laboratory medicine, was successfully held at the Anaheim Convention Center, USA.

As a leading platform for global clinical laboratory exchange, ADLM 2026 brought together laboratory medicine experts, industry partners, and innovative companies from around the world to explore emerging trends in diagnostic technology. Hotgen presented its comprehensive immunodiagnostic solutions at Booth 4020, showcasing the innovation and technological achievements of a Chinese IVD company in the field of immunodiagnostics.

Innovative Technologies Empowering Global Diagnostic Applications

At the exhibition, Hotgen showcased multi-platform immunodiagnostic solutions designed for a wide range of applications, including central laboratories, point-of-care testing (POCT), and public health.

In the field of chemiluminescence immunoassay, Hotgen presented innovative platforms covering diverse laboratory needs, including the MQ60 Series mono-test chemiluminescence immunoassay system, with over 18,000 installations analyzers worldwide; the C800 Fully Automated Chemiluminescence Immunoassay Analyzer, which ushers in a new era of small-molecule sandwich method testing; and the C2100 Whole Blood Fully Automated Chemiluminescence Immunoassay Analyzer. With flexible testing capabilities and broad application potential, these platforms support laboratories of different sizes with accurate, efficient, and multi-parameter testing solutions.

In the POCT field, the UPT2800 system, based on Hotgen’s proprietary Up-converting Phosphor Technology (UPT), provides rapid and reliable testing solutions for primary healthcare, emergency settings, and near-patient testing scenarios, featuring convenient operation and room-temperature storage and transportation advantages.

In addition, Hotgen showcased its TB-IGRA tuberculosis infection detection solution. Addressing global tuberculosis control needs, TB-IGRA detects immune responses induced by tuberculosis-specific antigens, providing accurate support for tuberculosis infection screening and clinical assessment, and contributing to infectious disease risk management and public health initiatives.

Connecting Global Partners to Drive Diagnostic Innovation

During the exhibition, Hotgen’s booth attracted attention from laboratory experts, healthcare representatives, and industry partners from various countries and regions. In-depth discussions were conducted on immunodiagnostic technology innovation, clinical application needs, and future collaboration opportunities.

Through ADLM 2026, an international platform for laboratory medicine, Hotgen further strengthened connections with global diagnostic partners and continued to promote the adoption of innovative diagnostic technologies worldwide.

Moving forward, Hotgen will remain committed to immunodiagnostic innovation, providing diversified diagnostic solutions to address global healthcare needs and contributing Chinese innovation to the advancement of precision medicine.

Exhibition Information

• Event: ADLM 2026 Annual Scientific Meeting & Clinical Lab Expo
  

• Date: July 28-30, 2026
  

• Venue: Anaheim Convention Center, California, USA
  

• Booth: 4020